Federal: HR1671
Justice for Vaccine Injured Veterans Act of 2025
Topics
Bill Information
Summary
Bill Summary
US HR 1671, the Justice for Vaccine Injured Veterans Act of 2025, amends title 38 of the United States Code to establish a presumption of service-connection for certain medical conditions potentially associated with COVID-19 vaccines for military personnel who received vaccination between August 24, 2021, and January 10, 2023. The bill covers myocarditis, pericarditis, thrombosis with thrombocytopenia syndrome, Guillain-Barré Syndrome, and any other disease the VA Secretary determines is vaccine-associated, allowing affected veterans to qualify for disability compensation without requiring documented evidence of the condition during military service. The legislation requires quarterly reports to Congress tracking vaccine-injury claims and mandates public access to these reports. The bill provides context around the 2021 Department of Defense vaccine mandate that resulted in over 8,400 discharges and was rescinded in January 2023.
Why It Matters to MAHA
MAHA supports this bill because it advances patient autonomy, informed consent, and transparency regarding vaccine safety concerns. The presumption of service-connection acknowledges that veterans who received mandated vaccines deserve access to benefits and medical care if they experience adverse effects, reflecting MAHA's core principle that individuals harmed by government health mandates deserve recognition and support. The mandatory public reporting requirement aligns with MAHA's commitment to transparency in healthcare and ensuring that safety data reaches the public rather than remaining hidden in bureaucratic channels. By creating pathways for veterans to obtain disability benefits for vaccine-associated injuries, the bill respects individual bodily autonomy and acknowledges that not all vaccine recipients experience the same health outcomes. This legislation reflects MAHA's belief that government should support those harmed by its own mandates rather than dismissing adverse event reports.